Relationship between HBsAg/HBV DNA and prognosis in patients with HBV-related hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors
Objectives: Blocking the programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) axis could reverse the immune tolerance in the liver microenvironment of hepatocellular carcinoma (HCC). We investigated the efficacy and the safety of PD-1/PD-L1 inhibitors and the possibility of hepatiti...
Saved in:
| Main Authors: | Qiuying Qin, Yuanyuan Zheng, Yiran Wang, Fei Zhou, Dong Li, Linlin Jin, Mujia Zhu, Yabing Guo, Rong Fan, Jinlin Hou, Xiaoyong Zhang, Hongyan Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251347469 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases
by: Zhongshu Pu, et al.
Published: (2025-05-01) -
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01) -
HBeAg testing is better than quantitative HBsAg assay as an alternative to HBV DNA assay among HBV-infected pregnant women
by: Minh Ngoc Nguyen, et al.
Published: (2023-10-01) -
Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01) -
Quantitative dynamic evaluation HBsAg in blood in comparison to viral load level in patients with chronic HBV-monoinfection
by: K. R. Dudina, et al.
Published: (2011-06-01)